Startup investors may not be hitting the pause button entirely on venture capital deployments, but a noticeable shift toward caution rippled through the market this past week. Following weeks of astronomical funding spikes dominated by multiple nine-figure and ten-figure syndicates, venture capitalists scaled back on giant rounds. During this mid-October 2026 cycle, only two startup financings crossed the multiple-hundred-million-dollar threshold.
Despite the slight cooling in overall mega-round frequency, capital continued to flow into vital technology and life sciences sectors. Artificial intelligence infrastructure, advanced construction automation, RNA and gene therapies, health-tech, specialized insurance, and semiconductor systems all captured substantial attention from leading institutional backers. The week’s activity demonstrated that while investors are being more selective about writing massive checks, high-growth companies with strong fundamentals and proven revenue trajectories can still command extraordinary valuations.
Leading the charge this week was AI infrastructure provider Modal Labs, which captured the lion’s share of venture capital attention with a massive Series D financing. Following closely behind was construction automation unicorn Icon, proving that heavy tech and physical-digital integration remain high-conviction plays for top-tier asset managers. Other sectors that successfully attracted large-scale capital included biotech innovators tackling serious genetic and kidney diseases, healthcare artificial intelligence platforms streamlining clinical workflows, climate-resilient insurance providers, and specialized semiconductor systems.
The Top Startup Funding Rounds in the U.S.
Topping the weekly charts by a wide margin, New York-headquartered Modal Labs secured an impressive $750 million in a Series D funding round. Led by prominent venture capital firm Accel, the massive infusion of capital values the AI infrastructure provider at an eye-popping $15.75 billion. Modal Labs has built a robust reputation as a premier provider of cloud infrastructure specifically optimized for AI inference and other heavy computational applications. The company underscored its explosive growth by revealing that it recently surpassed an annual revenue run rate of $1 billion, cementing its status as an indispensable backbone for the booming generative AI ecosystem.
Securing the second-largest deal of the week was Austin, Texas-based Icon, a prominent developer of robotic construction systems widely recognized for pioneering 3D-printed homes. Icon closed on $200 million in Series D funding in a syndicate co-led by major global institutional investors Baillie Gifford and BlackRock. The construction technology unicorn is scaling its operations rapidly, telling investors that it remains firmly on pace to achieve a remarkable fourfold increase in revenue over the course of 2026 as housing demand and automated building techniques converge.
The life sciences sector made a strong showing further down the list, highlighted by Boston-based Soufflé Therapeutics. The RNA therapeutics developer successfully raised $135 million in a Series B financing round. The investment was led by Juvia Group, which anchored a large and diverse syndicate of life science investors looking to back breakthrough genetic medicines.
Continuing the strong momentum in biotech, Menlo Park, California-based Estuary Biotherapeutics officially launched with an impressive $103 million in total financing. The company focuses on developing advanced genetic medicines designed specifically for patients suffering from serious and chronic kidney diseases. The newly announced capital structure comprises $93 million in a Series A round led by RA Capital Management, bolstered by an additional $10 million in previously undisclosed seed capital that helped lay the groundwork for the startup’s clinical pipeline.
Artificial intelligence tooling also remained a focal point for enterprise software investors. Labelbox, an 8-year-old San Francisco-based developer of technology used to train and evaluate AI models, secured $100 million in Series E funding. The financing was led by Infinitum Partners. Labelbox’s platform plays a critical role in helping organizations deploy autonomous agents that continuously improve through operational experience, addressing a core enterprise need for reliable training data and model evaluation.
In the healthcare technology space, Redwood City, California-based Suki announced a $90 million Series E financing round. Suki develops specialized AI tools designed to transform clinical conversations into actionable intelligence, automating complex medical documentation, billing coding, and other administrative healthcare workflows that traditionally burden physicians. The funding was backed by notable institutional investors, including Healthier Capital and Crosslink Capital, reflecting continued investor enthusiasm for administrative automation in clinical settings.
Family care and caregiving infrastructure captured venture capital interest through San Francisco-based Abby Care. The 5-year-old startup, which operates a platform designed to help family members become certified, paid caregivers capable of delivering professional-grade care directly in the home, closed on $82 million in Series C funding. The financing was led by Transformation Capital, signaling growing institutional backing for innovative models addressing the massive demand for home-based healthcare and family support systems.
Property technology and specialized risk management also made the top ten with San Francisco-based Stand. The three-year-old insurance provider specializes in offering coverage for residential homes located in geographic areas facing heightened risks of natural disasters. Stand secured $70 million in a Series C funding round that pushed its corporate valuation to the $1 billion unicorn milestone. The financing was led by Saga Ventures Management, highlighting how private markets are adapting insurance models to contend with escalating climate and environmental challenges.
Hardware and infrastructure scaling further down the stack attracted targeted investments, notably through Mueon Corp. The Portland, Oregon-based semiconductor systems company is building a modular platform designed specifically to power AI and hyperscale computing environments. Mueon completed a $65 million Series A funding round led by Maverick Silicon, pointing to the sustained hardware-level race to support expanding artificial intelligence workloads.
Rounding out the top ten financing rounds for the week, New York-based North.cloud raised $60 million in a Series B round. The company provides an infrastructure spend intelligence and automation platform that helps enterprises manage and optimize their ballooning cloud and AI computational expenses. The financing was led by PeakSpan Capital, reflecting a broader enterprise focus on cost control and financial efficiency amidst heavy digital transformation spending.
Methodology
The data underlying this weekly roundup tracks the largest announced venture capital funding rounds gathered within the Crunchbase database raised by U.S.-based companies. The tracked period covers activity from October 10 through October 16, 2026. While the vast majority of publicly announced venture rounds are promptly integrated into the database, a minor time lag may occasionally occur for transactions reported toward the very end of the business week.
